Frequency of Anti-Thyroid Peroxidase (Anti-TPO) in Diabetes Mellitus Type 1 Patients

Authors

  • Alia Bibi, Muhammad Kamran, Jawaria Alvi, Muhammad Musawar Mushtaq Author

DOI:

https://doi.org/10.71395/ijhp.1.3.2024.8-12

Abstract

Background and Objectives: The association between autoimmune thyroiditis and diabetes mellitus type 1 is of great significance, as both are autoimmune disorders. The presence of one autoimmune disorder increases the risk of developing another autoimmune disorder. To determine the frequency of anti-thyroid peroxidase (anti-TPO) antibodies in individuals diagnosed with diabetes mellitus type 1. On the basis of gender, age and among the diagnosed patients of hypothyroidism and hyperthyroidism with diabetes mellitus type 1.
METHODOLOGY: A retrospective study was conducted in University of Lahore Teaching Hospital, Lahore, Punjab. The study was conducted during the 3 months from May to July, 2023. The research involved examining of 135 diabetes type 1 patients, with an average age of 27.44 years, comprising 60 males (44.44%) and 75 females
(55.56%) with different age groups. Cobas C-311 and Enzyme-linked Immunosorbent assay (ELISA) were used to analyze glycosylated hemoglobin (HbA1c) and anti-thyroid peroxidase antibodies (anti-TPO) respectively. A self-designed Performa was used to collect the patient data. Data were entered and analyzed by using excel and
displayed by using Tables and Bar Charts.
RESULTS: Anti-TPO antibodies were detected in 25 patients (18.52%) out of the 135 participants, although they were absent in 110 patients (81.48%). Notably, females (76%) were more likely to have anti-TPO antibodies than men (24%), especially in those between the ages of 10 and 25 (64%). Only one of the 135 people had anti-TPO antibodies, despite the fact that five of them had hypothyroidism. Three of the 135 patients were diagnosed cases of hyperthyroidism, and all three were anti-TPO negative.

CONCLUSION: The conclusion of this study is that anti-TPO antibodies are very common in diabetes mellitus type 1 patients and gender and age have a significant impact on the formation of anti-TPO antibodies.

Author Biography

  • Alia Bibi, Muhammad Kamran, Jawaria Alvi, Muhammad Musawar Mushtaq

    Department of Pathology, The University of Faisalabad

References

Atkinson MA, Campbell-Thompson M, Kusmartseva I, Kaestner KH. Organisation of the human pancreas in health and in diabetes. Diabetologia. 2020;63:1966-73.

DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. The Lancet. 2018;391(10138):2449-62.

Gale EA. The discovery of type 1 diabetes. Diabetes. 2001;50(2):217-26.

Lernmark A. Type 1 diabetes. Clinical chemistry. 1999;45(8):1331-8.

Roche EF, Menon A, Gill D, Hoey H. Clinical presentation of type 1 diabetes. Pediatric diabetes. 2005;6(2):75-8.

Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Fard HH, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health promotion perspectives. 2020;10(2):98-101.

Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan: A silent killer. Annals of medicine and surgery. 2022;79-81.

Benvenga S, Tuccari G, Ieni A, Vita R. Thyroid gland: anatomy and physiology. Encyclopedia of Endocrine Diseases. 2018;4:382-90.

Brent GA. Mechanisms of thyroid hormone action. The Journal of clinical investigation. 2012;122(9):3035-43.

Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. New England journal of medicine. 1996;335(2):99-107.

Duntas LH. Environmental factors and autoimmune thyroiditis. Nature clinical practice Endocrinology & metabolism. 2008;4(8):454-60.

Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am. 2001;30(2):315-37.

Williams DE, Le SN, Godlewska M, Hoke DE, Buckle AM. Thyroid peroxidase as an autoantigen in Hashimoto’s disease: structure, function, and antigenicity. Hormone and Metabolic Research. 2018;50(12):908-21.

Orzan A, Novac C, Mihaiela M, Tirgoviste CI, Balgradean M. Type 1 diabetes and thyroid autoimmunity in children. Maedica. 2016;11(4):308.

Mouradian M, Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care. 1983;6(5):512-20.

Sharma B, Nehara HR, Saran S, Bhavi VK, Singh AK, Mathur SK. Coexistence of autoimmune disorders and type 1 diabetes mellitus in children: an observation from western part of India. Indian journal of endocrinology and metabolism. 2019;23(1):22-6.

Konar H, Sarkar M, Roy M. Association of thyroid dysfunction and autoimmunity in pregnant women with diabetes mellitus. The Journal of Obstetrics and Gynecology of India. 2018;68:283-8.

Riquetto ADC, de Noronha RM, Matsuo EM, Ishida EJ, Vaidergorn RE, Soares Filho MD, et al. Thyroid function and autoimmunity in children

and adolescents with Type 1 Diabetes Mellitus. Diabetes research and clinical practice. 2015;110(1):9-11.

Kakleas K, Paschali E, Kefalas N, Fotinou A, Kanariou M, Karayianni C, et al. Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Upsala journal of medical sciences. 2009;114(4):214-20.

Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Grüters‐Kieslich A. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. Diabetic medicine. 2002;19(6):518-21.

Downloads

Published

2024-09-30

How to Cite

Frequency of Anti-Thyroid Peroxidase (Anti-TPO) in Diabetes Mellitus Type 1 Patients. (2024). International Journal of Healthcare Professions, 1(3). https://doi.org/10.71395/ijhp.1.3.2024.8-12